Bacterial skin colonization and infections in patients with atopic dermatitis;Colonização bacteriana e infecções da pele em pacientes com dermatite atópica

Anais Brasileiros de Dermatologia

Volumn 87, Issue 5, 2012, Pages 729-734

  Petry, Vanessa ^a   Bessa, Giancarlo Resende ^a   Poziomczyck, Claudia Schermann ^a   de Oliveira, Caio Fernando ^a   Weber, Magda Blessmann ^a   Bonamigo, Renan Rangel ^a   d'Azevedo, Pedro Alves ^a  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

Atopic; Bacterial; Bacterial growth; Bacterial infections; Dermatitis; Transformation

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFACLOR; CEFADROXIL; CEFALEXIN; CEPHALOSPORIN DERIVATIVE; CHLORHEXIDINE; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; HYPOCHLORITE SODIUM; MACROLIDE; PSEUDOMONIC ACID; RETAPAMULIN; TRICLOSAN;

ABDOMINAL PAIN; AGRANULOCYTOSIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; ATOPIC DERMATITIS; BACTERIAL COLONIZATION; BACTERIAL SKIN DISEASE; COLITIS; DIARRHEA; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DYSPNEA; EOSINOPHILIA; FACE EDEMA; FEVER; GASTROINTESTINAL SYMPTOM; GROUP A STREPTOCOCCAL INFECTION; HEMOLYTIC ANEMIA; HUMAN; HYPERTRANSAMINASEMIA; IMPETIGO; JAUNDICE; LONG TERM CARE; MACULOPAPULAR RASH; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOUTH EDEMA; NAUSEA; NEUTROPENIA; NONHUMAN; PRESCRIPTION; PRURITUS; PSEUDOMEMBRANOUS COLITIS; RECOMMENDED DRUG DOSE; SECONDARY INFECTION; SERUM SICKNESS; SIDE EFFECT; SKIN ALLERGY; SKIN FLORA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES; SYSTEMIC THERAPY; THROMBOCYTOPENIA; TREATMENT DURATION; URTICARIA; VOMITING;

ANTI-BACTERIAL AGENTS; DERMATITIS, ATOPIC; HUMANS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84867829441     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962012000500010     Document Type: Article

References (77)

1. Fels JM. Atopic dermatitis: an update. J Am Acad Dermatol. 1996;35:1-13.
2. Ruzicha T. Atopic eczema between rationality and irrationality. Arch Dermatol. 1998;134:1462-9.
3. Wuthrich B. Epidemiology and natural history of atopic dermatitis. Allergy Clin Immunol Int. 1996;8:77-82.
4. Wollenberg A, Räwer HC, Schauber J. Innate Immunity in Atopic Dermatitis. Clin Rev Allergy Immunol. 2011;41:272-81.
5. Lowy FD. Staphylococcus aureus infections. N Eng J Med.1998:339:520-32.
6. Paulsen IT, Firth N, Skurray RA. Resistance to antimicrobial agents other than betalactams. In: Crossley KB, Archer Gl, editors. The staphylococci in human disease. New York: Churchill Livingstone; 1997. p.175-212.
7. Rossi F, Andreazzi DB. Resistência bacteriana: interpretando o antibiograma. São Paulo: Editora Atheneu; 2005. p.26-63.
8. Dunkle LM, Naqvi SH, McCallum R, Lofgren IP. Eradication of epidemic methicillingentamicin-resistant Staphylococcus aureus in an intensive care nursery. Am J Med. 1981;70:455-458.
9. Breuer K, Kappa A, Werfel T. Bacterial infections and atopic dermatitis. Allergy. 2001;56:1034-41.
10. Guzik TJ, Bzowska M, Kasprowicz A, Czerniawska-Mysik G, Wójcik K, Szmyd D, et al. Persistent skin colonization with staphylococcus aureus in atopic dermatitis: relationship to clinical and immunological parameters. Clin Exp Allergy. 2005;35:448-55.
11. Goh CL, Wong JS, Giam YC. Skin colonization of Staphylococcus aureus in atopic dermatitis patients seen at the National Skin Centre, Singapore. Int J Dermatol. 1997;36:653-7.
12. Matsui K, Nishikawa A, Suto H, Tsuboi R, Ogawa H. Comparative study of Staphylococcus aureus isolated from lesional and non-lesional skin of atopic dermatitis patients. Microbiol Immunol. 2000;44:945-7.
13. Vickery BP. Skin barrier function in atopic dermatitis. Curr Opin Ped. 2007;19:89-93.
14. McGrath JA, Uitto J. The filaggrin story: novel insights into skin-barrier function and disease. Trends Mol Med. 2008;14:20-7.
15. Addor FAS, Aoki V. Barreira cutânea na dermatite atópica. An Bras Dermatol. 2010;85:184-94.
16. Vu AT, Baba T, Chen X, Le TA, Kinoshita H, Xie Y, et al. Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes through the Toll-like receptor 2-Toll-like receptor 6 pathway. J Allergy Clin Immunol. 2010;126:985-93.
17. Kozman A, Yao Y, Bina P, Saha C, Yao W, Kaplan MH, et al. Encoding a superantigen by Staphylococcus aureus does not affect clinical characteristics of infected atopic dermatitis lesions. Br J Dermatol. 2010;163:1308-11.
18. Cho SH, Strickland I, Boguniewicz M, Leung DY. Fibronectin and fibrinogen contribute to the enhanced binding of Stphylococcus aureus to atopic skin. J Am Acad Dermatol 2001;108:269-74.
19. Farajzadeh S, Rahnama ZZ, Kamyabi Z, Ghavidel B. Bacterial colonization and antibiotic resistance in children with atopic dermatitis. Derm Online J. 2008;14:21.
20. Kedzierska A, Kapińska-Mrowiecka M, Czubak-Macugowska M, Wójcik K, Kedzierska J. Susceptibility testing and resistance phenotype detection in Staphylococcus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization. Br J Dermatol. 2008;159:1290-9.
21. Londero RM, Giugliani ER, Bonamigo RR, Bauer VS, Cecconi MCP, Zubaran GM. Aleitamento materno e colonização muco-cutânea pelo staphylococcus aureus na criança com dermatite atópica. An Bras Dermatol. 2011;86:435-9.
22. Lina G, Piémont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, et al. Involvement of Panton-Valentineleukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis. 1999;29:1128-32.
23. Saravolatz LD; Markowitz N, Arking L, Pohlod D, Fisher E. Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med. 1982;96:11-6.
24. Ho M, McDonald LC, Lauderdale TL, Yeh LL, Chen PC, Shiau TR. Survellance of antibiotic resitant in Taiwan, 1998. J Microbiol Infect. 1999;32:239-49.
25. Jernigan J. Methicillin resistant Staphylococcus aureus in the community: infection control strategies. Program and abstracts of the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy; 2004 Oct 30-Nov 2. Washington, DC: ICAAC; 2004. Session 153; Abstract
26. Layton MC, Hierholzer Jr WJ, Patterson JE. The evolving epidemiology of carriage of methicillin-resitant Staphylococcus aureus at a university hospital. Infect Control Hosp Epidemiol. 1995;16:12-7.
27. Madani TA, Al Abdullah NA, Al-Sanousi AA, Ghabrah TM, Afandi SZ, Bajunid HA. Methicillin-resistant Staphylococcus aureus in two tertiary-care centers in Jeddah, Saudi arábia. Infect Control Hosp Epidemiol. 2001;22:211-6.
28. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, et al. Comparison of community and health care associated methicillin-resistant infection. JAMA. 2003;290:2976-2984.
29. Naimi TS, LeDell KH, Boxrud DJ, Groom AV, Steward CD, Johnson SK, et al. Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. Clin Infect Dis. 2001;33:990-6.
30. Ribeiro A, Dias C, Silva-Carvalho MC, Berquó L, Ferreira FA, Santos RN, et al. First report of infection with community-acquired methicillin-resistant Staphylococcus aureus in South America. J Clin Microbiol. 2005;43:1985-8.
31. Rings T, Lang FS. Ethnicity and methicillin-resistant Staphylococcus aureus in South Auckland. N Z Med J. 1998;111:151.
32. Varkila J. Community-acquired methicillinresistant Staphylococcus aureus, Finland. Emerg Infect Dis. 2002;8:602-7.
33. Shahin R, Johnson LL, Jamieson F, McGeer A, Tolkin J, Ford-Jones EL,. Methicillinresistant Staphylococcus aureus carriage in a child care center following a case of disease. Arch Pediatr Adolesc Med. 1999;153:864-868.
34. Stacey AR, Endersby KE, Chan PC, Marples RR. An outbreak of methicillin-resistant Staphylococcus aureus infection in a rugby football team. Br J Sports Med. 1999;32:2233-2239.
35. Vandenesch F, Naimi T, Enright MC, Lina G, Nimmo GR, Heffernan H, et al. Community-acquired methicilin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes:wordwide emergence. Emerg Infect Dis. 2003;9:978-84.
36. Baggett HC, Hennessy TW, Leman R, Hamlin C, Bruden D, Reasonover A, et al. An outbreak of community-onset methicillin-resistant skin infections in south-western Alaska. Infect Control Hosp Epidemiol. 2003;24:397-402.
37. Dufour P, Gillet Y, Bes M, Lina G, Vandenesch F, Floret D, et al. Community-acquired methicillin-resistant infections in France:emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 2002;35:819-24.
38. d'Azevedo PA, Inoue FM, Andrade SS, Tranchesi R, Pignatari AC. Necrotizing pneumonia due to methicillin-resistant Staphylococcus aureus. Rev Soc Bras Med Trop. 2009;42:461-2.
39. Gelatti LC, Sukiennik T, Becker AP, Inoue FM, do Carmo MS, Castrucci FM, et al. Sepsis due to community-acquired methicillin-resistant Staphylococcus aureus in southern Brazil. Rev Soc Bras Med Trop. 2009;42:458-60.
40. Roesch A, Linde HJ, Landthaler M, Vogt T. Elimination of a community-acquired methicillin-resistant Staphylococcus aureus infection ina nurse with atopic dermatitis. Arch Dermatol. 2005;141:1520-2.
41. Hon KL, Leung AK, Kong AY, Leung TF, Ip M. Atopic dermatitis complicated by methicillin-resistant Staphylococcus aureus infection. J Nath Med Assoc. 2008;100:797-800.
42. Suh LM, Honig PJ, Yan AC. Methicilin-resistent Staphylococcus aureus skin abcesses in a pediatric patient with atopic dermatitis: a case report. Cutis. 2006;78:113-6.
43. Hoeger PH. Antimicrobial susceotibility of skin-colonizing S aureus strains in children with atopic dermatitis. Pediatr Allergy Immunol. 2004;15:474-7.
44. Balma-Mena A, Lara-Corrales I, Zeller J, Richardson S, McGavin MJ, Weinstein M, et al. Colonization with community-acquired methicillin-resistant Staphylococcus aureus in children with atopic dermatitis: a cross-sectional study. Int J Dermatol. 2011;50:682-8.
45. Breuer K, Haussler S, Kapp A, Werfel T. Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis. Br J Dermatol. 2002;147:55-61.
46. Jappe U, Schnuch A, Uter W. Frequency of sensitization to antimicrobials in patients with atopic eczema compared with nonatopic individuals: analysis of multicentre surveillance data, 1995-1999. Br J Dermatol. 2003;149:87-93.
47. Hill S, Yung A, Rademaker M. Prevalence of Staphylococcus aureus and antibiotic resistance in children with atopic dermatitis: A New Zealand experience. Australas J Dermatol. 2011;52:27-31.
48. Matiz C, Tom WL, Eichiefield LF, Pong A, Friedlander SF. Children with Atopic Dermatitis Appear LessLikely to Be Infected with Community Acquired Methicillin-Resistant Staphylococcus aureus: the San Diego experience. Pediatr Dermatol. 2011;28:6-11.
49. Gomes PL, Malavige GN, Fernando N, Mahendra MH, Kamaladasa SD, Seneviratne JK, et al. Characteristics of Shaphylococcus aureus colonization in patients with atopic dermatitis in Sri Lanka. Clin Exp Dermatol. 2011;36:195-200.
50. Tang CS, Wanf CC, Huang CF, Chen SJ, Tseng MH, Lo WT. Antimicrobial susceptibility of Staphyloccoccus aureus in children with atopic dermatitis. Pediatr Int. 2011;53:363-7.
51. Ortega-Loayza AG, Diamantis SA, Gilligan P, Morrell DS. Characterization of Staphylococcus aureus cutaneous infections in a pediatric dermatology tertiary health care outpatient facility. J Am Acad Dermatol. 2010;62:804-11.
52. Suh L, Coffin S, Leckerman KH, Gelfand JM, Honig PJ, Yan AC. Methicilin-Resistant Sthaphylococcus aureus Colonization in Children with Atopic Dermatitis. Pediatr Dermatol. 2008;25:528-34.
53. Chung HJ, Jeon HS, Sung H, Kim MN, Hong SJ. Epidemiological Characterirstics of Methicilin-Resistant Staphylococcus aureus Isolates from Children with Eczematous Atopic Dermatitis Lesions. J Clin Microbiol. 2008;46:991-5.
54. Mandell GL, Bennett JE, Dolin R. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2009. p. 2591
55. Adachi J, Endo K, Fukuzumi T, Tanigawa N, Aoki T. Increasing incidence of streptococcal impetigo in atopic dermatitis. J Dermatol Sci. 1998;17:45-53.
56. Hayakawa K, Hirahara K, Fukuda T, Okazaki M, Shiohara T. Risk factors for severe impetiginized atopic dermatitis in Japan and assessment of its microbiological features. Clin Exp Dermatol. 2009;34:e63-5.
57. Akiyama H, Yamasaki O, Kanzaki H, Tada J, Arata J. Streptococci isolated from various skin lesions: interaction with Staphylococcus aureus strains. J Dermatol Sci. 1999;19:17-22.
58. Coonan K, Kaplan EL. Therapeutic implications of erythromycin resistance in group A streptococci. Pediatr Infect Dis J. 1993;12:261-2.
59. Gelmetti C. Local antibiotics in dermatology. Derm Ther. 2008;21:187-95.
60. Koning S, Verhagen AP, van Suijlekom-Smit LW, Morris A, Butler CC, van der Wouden JC. Interventions for impetigo. Cochrane Database Syst Rev. 2004;CD003261.
61. Alsterholm M, Flytström I, Bergbrant IM, Faergemann J. Fusidic acid-resistant Staphylococcus aureus in impetigo contagiosa and secondarily infected atopic dermatitis. Acta Derm Venereol. 2010;90:52-7.
62. Howden BP, Grayson ML. Dumb and dumber--the potential waste of a useful antistaphylococcal agent: emerging fusidic acid resistance in Staphylococcus aureus. Clin Infec Dis. 2006;42:394-400.
63. Arkwright PD, Daniel TO, Sanyal D, David TJ, Patel L. Age-Related Prevalence and Antibiotic Resistance of Pathogenic Staphylococci and Streptococci in Children With Infected Atopic Dermatitis at a Single-Specialty Center. Arch Dermatol. 2002;138:939-41.
64. Lio PA, Kaye ET. Topical antibacterial agents. Infect Dis Clin North Am. 2009;23:945-63, ix.
65. BRASIL. Resolução-RDC n. 20, de 5 de maio de 2011. Dispõe sobre o controle de medicamentos a base de substâncias classificadas como antimicrobianos, de uso sob prescrição médica, isoladas ou em associação e dá outras providências. Diário Oficial da União 9 maio 2011; Seção
66. Dubois EA, Cohen AF. Retapamulin. Br J Clin Pharmacol. 2010;69:2-3.
67. Moody MN, Morrison LK, Tyring SK. Retapamulin: what is the role of this topical antimicrobial in the treatment of bacterial infections in atopic dermatitis? Skin Ther Letter. 2010;15:1-4.
68. Huang JT, Abrams M, Tlougan B, Rademaker A, Paller AS. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics. 2009;123:808-14.
69. Schuttelaar ML, Coenraads PJ. A randomized, double-blind study to assess the efficacy of addition of tetracycline to triamcinolone acetonide in the treatment of tetracycline to triamcinolone acetonide in the treatment of moderate to severe atopic dermatitis. J Eur Acad Dermatol Venereol. 2008;22:1076-82.
70. Cardona ID, Cho SH, Leung DY. Role of bacterial superantigens in atopic dermatitis: implications for future therapeutic strategies. Am J Clin Dermatol. 2006;7:273-9.
71. Lupi O, Belo J, Cunha P. Rotinas de Diagnóstico e Tratamento da Sociedade Brasileira de Dermatologia-SBD. Itapevi, SP: Guanabara Koogan; 2010. Capítulo 17, Dermatite Atópica; p.
72. Gong JQ, Lin L, Lin T, Hao F, Zeng FQ, Bi ZG, et al. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial. Br J Dermatol. 2006;155:680-7.
73. Shaw MG, Burkhart CN, Morrel DS. Systemic therapies for pediatric atopic dermatitis: a review for the primary physician. Pediatric Ann. 2009;38:380-7.
74. Bath-Hextall FJ, Birnie AJ, Ravenscroft JC, Williams HC. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review. Br J Dermatol. 2010;163:12-26.
75. Leung DYM, Bieber T. Atopic dermatitis. Lancet. 2003;361:151-60.
76. Wolverton SE. Comprehensive dermatologic drug therapy. Philadelphia: WB Saunders
77. Sidbury R, Hanifin JM. Systemic therapy of atopic dermatitis. Clin Exp Dermatol. 2000;25:559-66.